Monte Rosa Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 7.69 M | $40.77 M | 0.00% | 9.38% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 6.60 M | $34.99 M | 10.43% | 8.05% |
AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 5.79 M | $30.69 M | 27.68% | 7.06% |
FMR LLC | 11/13/2024 | 5.10 M | $27.04 M | 0.13% | 6.22% |
BAKER BROS. ADVISORS LP | 11/14/2024 | 4.92 M | $26.06 M | 0.00% | 5.99% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.90 M | $15.38 M | 100.00% | 3.54% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 2.66 M | $14.09 M | 0.00% | 3.24% |
VANGUARD GROUP INC | 11/13/2024 | 2.53 M | $13.43 M | -0.50% | 3.09% |
AISLING CAPITAL MANAGEMENT LP | 11/13/2024 | 1.47 M | $7.80 M | 0.00% | 1.80% |
ALPHABET INC. | 11/08/2024 | 1.46 M | $7.76 M | 0.00% | 1.79% |
CITADEL ADVISORS LLC | 11/14/2024 | 1.16 M | $6.14 M | 16.37% | 1.41% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.04 M | $5.54 M | 23.28% | 1.27% |
VESTAL POINT CAPITAL, LP | 11/14/2024 | 930,000 | $4.93 M | 4.49% | 1.13% |
STATE STREET CORP | 11/14/2024 | 687,577 | $3.64 M | 8.10% | 0.84% |
PARKWOOD LLC | 11/14/2024 | 426,620 | $2.26 M | 100.00% | 0.52% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 393,586 | $2.09 M | 28.07% | 0.48% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 346,498 | $1.84 M | 11.13% | 0.42% |
IKARIAN CAPITAL, LLC | 11/14/2024 | 311,593 | $1.65 M | 100.00% | 0.38% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 218,700 | $1.16 M | -14.14% | 0.27% |
WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 217,001 | $1.15 M | 30.20% | 0.26% |
TD ASSET MANAGEMENT INC | 11/01/2024 | 193,696 | $1.00 M | 0.00% | 0.24% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 178,605 | $946,606 | 93.40% | 0.22% |
MARSHALL WACE, LLP | 11/14/2024 | 173,849 | $921,400 | 100.00% | 0.21% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 166,693 | $883,472 | 51.73% | 0.20% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 139,273 | $738,147 | -9.42% | 0.17% |
MORGAN STANLEY | 11/14/2024 | 125,332 | $664,260 | 83.39% | 0.15% |
SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 118,103 | $625,946 | -68.51% | 0.14% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 117,877 | $624,748 | 14.77% | 0.14% |
ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 110,835 | $586,000 | 12.46% | 0.14% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 102,835 | $545,026 | 15.42% | 0.13% |
BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 91,292 | $483,848 | 100.00% | 0.11% |
CASDIN CAPITAL, LLC | 11/14/2024 | 86,014 | $455,874 | -67.05% | 0.10% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 73,419 | $389,120 | 7.18% | 0.09% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 71,100 | $376,830 | -1.93% | 0.09% |
CITADEL ADVISORS LLC | 11/14/2024 | 69,700 | $369,410 | 495.73% | 0.09% |
AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 60,365 | $319,935 | 22.17% | 0.07% |
BARCLAYS PLC | 11/19/2024 | 54,508 | $289,000 | 395.12% | 0.07% |
RHUMBLINE ADVISERS | 11/12/2024 | 52,468 | $278,070 | 9.48% | 0.06% |
LONG CORRIDOR ASSET MANAGEMENT LTD | 11/12/2024 | 40,000 | $212,000 | 0.00% | 0.05% |
HRT FINANCIAL LP | 11/12/2024 | 38,911 | $206,000 | 100.00% | 0.05% |
STATE OF WISCONSIN INVESTMENT BOARD | 11/14/2024 | 36,300 | $192,390 | -20.22% | 0.04% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 35,140 | $186,242 | 7.20% | 0.04% |
ENTRYPOINT CAPITAL, LLC | 11/13/2024 | 33,219 | $176,061 | 100.00% | 0.04% |
CITADEL ADVISORS LLC | 11/14/2024 | 31,200 | $165,360 | 267.06% | 0.04% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 30,621 | $162,291 | 46.32% | 0.04% |
EXCHANGE TRADED CONCEPTS, LLC | 10/10/2024 | 29,798 | $157,929 | -16.50% | 0.04% |
UBS GROUP AG | 11/14/2024 | 25,333 | $134,265 | 8.75% | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 25,000 | $132,500 | 100.00% | 0.03% |
METLIFE INVESTMENT MANAGEMENT, LLC | 11/13/2024 | 24,855 | $131,732 | 100.00% | 0.03% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 22,617 | $119,870 | 39.01% | 0.03% |
Monte Rosa Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 87 institutional investors and hedge funds held shares of Monte Rosa Therapeutics, Inc.. The most heavily invested institutionals were:
NEA Management Company, LLC: 7.69 M
PRICE T ROWE ASSOCIATES INC /MD/: 6.6 M
Avoro Capital Advisors LLC: 5.79 M
FMR LLC: 5.1 M
BAKER BROS. ADVISORS LP: 4.92 M
BlackRock Funding, Inc. /DE: 2.9 M
60.69% of Monte Rosa Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 51.73 M shares in the last 24 months. This purchase volume represents approximately $370.88 M in transactions.